Thymosin Alpha 1
Thymosin Alpha-1 (Tα1) is a 28-amino acid peptide derived from prothymosin alpha, widely recognized as a critical immunomodulator that enhances T-cell function and balances immune responses.
Thymosin Alpha-1 enhances CD8+ cytotoxic T lymphocyte activity and natural killer (NK) cells while improving antigen-presenting cell (APC) function through TLR9 signaling and MHC expression.
Research demonstrates its ability to regulate cytokine production, balancing pro-inflammatory and anti-inflammatory responses while converting suppressor T-cells to helper T-cells in immunocompromised models.
Studies show protection against oxidative stress and support for cellular repair, with documented benefits in infectious diseases, cancer immunotherapy, and immunosenescence associated with aging.
Thymosin Alpha-1 modulates enhanced adaptive immunity, balanced inflammatory responses, and improved pathogen clearance, making it essential for research in immune dysregulation, chronic infections, and age-related immune decline.
Composition: Thymosin Alpha-1 (5 mg)